FDA’s Role in Postmarketing Drug Safety Surveillance
- Describe FDA’s drug safety surveillance system at the Center for Drug Evaluation and Research (CDER).
- Explain the MedWatch Program and how you can have an impact on signal detection.
- Discuss how adverse event reports are collected and analyzed.
- Demonstrate how safety findings are communicated to the public.
Additional Resources: FDA'sRoleinPostmarketingDrugSafetySurvillance_Slides